Abstract
Selection of the correct analytical technique from the outset of method development is key in securing the optimal and most robust method to be used throughout a product’s development journey from R&D to commercialization. In this article, we review some key considerations for chromatographic technique selection and method development across the full drug process—from early-stage API synthesis to routine commercial release activities. We describe the implementation of supercritical fluid chromatography (SFC) in the pharmaceutical industry, especially for chiral, water sensitive analytes, and low to high LogP and LogD hydrophobic compounds, while demonstrating high levels of method robustness and support of “green” analytics.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
